OK-432¸¦ ÀÌ¿ëÇÑ ´Ü¼ø ½Å³¶Á¾ÀÇ °æÇÇÀû °æÈ¿ä¹ý
Treatment of Simple Renal Cysts by Percutaneous Aspiration and OK-432 Sclerotherapy
¹Ú¼ºÁø, ±è¿øÅÂ, Á¶¼º¿ë, À̵¿ÈÆ, Á¶°¼ö, ÇÔ¿ø½Ä, ÃÖ¿µµæ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¼ºÁø ( Park Sung-Jin )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±è¿øÅ ( Kim Won-Tae )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¶¼º¿ë ( Cho Soung-Yong )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
À̵¿ÈÆ ( Lee Dong-Hoon )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¶°¼ö ( Cho Kang-Su )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç, ºñ´¢ÀÇ°úÇבּ¸¼Ò
ÇÔ¿ø½Ä ( Ham Won-Sik )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç, ºñ´¢ÀÇ°úÇבּ¸¼Ò
ÃÖ¿µµæ ( Choi Young-Deuk )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç, ºñ´¢ÀÇ°úÇבּ¸¼Ò
KMID : 0358320080490100917
Abstract
Purpose: Percutaneous aspiration with sclerotherapy has been widely used for the treatment of symptomatic or large simple renal cysts. Ethanol has been most commonly used as a sclerosing agent; however, a temporary percutaneous nephrostomy for multiple ethanol injections is necessary to achieve a low recurrence rate. Thus, we used OK-432 as a new sclerosing agent without a temporary percutaneous nephrostomy for multiple injections, and also compared our results with the results of previous studies.
Materials and Methods: Between October 2005 and April 2006, 50 patients (63 simple renal cysts) who underwent percutaneous OK-432 sclerotherapy for simple renal cysts were evaluated. The simple renal cysts were aspirated under ultrasonography and fluoroscopy, after which OK-432 was injected into the cyst. Follow-up was performed with ultrasonography or CT scan after 3 months. Regression of the renal cyst or a £¾70% reduction in size with no symptoms was considered a treatment success.
Results: Among 63 renal cysts in 50 patients, complete regression occurred in 17(27.0%). Greater than a 90% reduction in size occurred in 8(12.7%), a 80-90% reduction in size occurred in 21(33.3%), and a 70-80% reduction in size occurred in 15(23.8%); a £¼70% reduction in size occurred in 2 (3%). The overall efficacies of success were 96.8%. After the procedure, there were only some minor complications, such as mild fever, local pain, and liver function test elevation that subsided with symptomatic treatment.
Conclusions: Percutaneous OK-432 sclerotherapy is simple, safe, and effective and can be an alternative first-line therapy of simple renal cysts.
Å°¿öµå
Renal cyst;OK-432;Sclerotherapy
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸